Stephen Hoge - Apr 15, 2024 Form 4 Insider Report for Moderna, Inc. (MRNA)

Role: President
Signature: /s/ James Dillon, as Attorney-in-Fact
Stock symbol: MRNA
Transactions as of: Apr 15, 2024
Transactions value $: -$1,575,300
Form type: 4
Date filed: 4/16/2024, 04:23 PM
Previous filing: Mar 19, 2024
Next filing: May 13, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MRNA	Common Stock	Sale	-$1.58M	-15K	-1%	$105.02	1.49M	Apr 15, 2024	Direct	F1
holding	MRNA	Common Stock						4.12K	Apr 15, 2024	By Valhalla, LLC
holding	MRNA	Common Stock						152K	Apr 15, 2024	By Trust	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id	Content
F1	The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 15, 2023.
F2	These shares are owned directly by a trust for the benefit of Dr. Hoge's spouse and children, of which his spouse is a trustee. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose.

Content

The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 15, 2023.

These shares are owned directly by a trust for the benefit of Dr. Hoge's spouse and children, of which his spouse is a trustee. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose.